"To meet our biotech and biomedical needs, the country needs to be self-reliant for product manufacturing and also the components, reagents, resources across the product development chain. National Biomedical Resources Indigenization Consortium (NBRIC) constituted by DBT brings together academia, industry, startups and MSME to serve not just the country but the world.  To meet the COVID 19 challenges, this is a good start and we hope to enlarge this to include all required resources, platforms and facilities.

Within a month, the Consortium has seen active engagement from several major stakeholders of Indian biomedical resources innovation community. 30 companies, big, medium and small, and academic/research institutes have come on board with the common goal of furthering the boundaries of India’s present capabilities in biomedical resources towards greater self-reliance and to cement our role as a key player in global biotech domain."

Dr Renu Swarup, Secretary, Department of Biotechnology, Government of India, New Delhi